Sign in
CompletedPhase 3

The Effect of Mannitol Volume With Changes in Osmolarity in Traumatic Brain Injury

Key facts

Who runs it
Universitas Diponegoro
Where
Indonesia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
64 people enrolled
Started
1 Nov 2023
Ended
31 Jan 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mannitol
Record updated
11 June 2026

Who can take part

Age
18 years to 40 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients aged 18-40 years
  • Glasgow Coma Scale (GCS) score indicating mild (14-13) or moderate (12-10)

Who cannot take part

  • Renal impairment
  • Multiple trauma with bleeding shock
  • Diabetes mellitus

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This observational study is designed to research the effect of mannitol volume administration with changes in osmolarity in patients with traumatic brain injury to guide the safe use of mannitol in these patients.

The 3 groups in the trial

  • Mannitol 1Existing treatment, for comparison

    3×0.25 g/kg

    Treatment: Mannitol

  • Mannitol 2Existing treatment, for comparison

    2×0.5 g/kg

    Treatment: Mannitol

  • Mannitol 3Existing treatment, for comparison

    3×0.5 g/kg

    Treatment: Mannitol

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Mannitol Volume Administration With Changes in Osmolarity in Traumatic Brain Injury: An Observational Study
Record updated
11 June 2026